Zobrazeno 1 - 10
of 24
pro vyhledávání: '"D. A. Filonenko"'
Autor:
Yu. A. Vasyuk, E. Y. Shupenina, E. O. Novosel, D. A. Vyzhigin, A. G. Nosova, L. G. Zhukova, D. A. Filonenko, E. I. Khatkova
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 12 (2023)
Aim. To search early signs of cardiotoxicity in patients receiving anticancer therapy and evaluate the effectiveness of cardioprotection with an angiotensin-converting enzyme inhibitor, beta-blocker and myocardial cytoprotector.Material and methods.
Externí odkaz:
https://doaj.org/article/7a16fd7564fb4f71a499eab7266fdb42
Autor:
D. A. Filonenko, T. M. Ibragimova, N. I. Polshina, A. V. Belogurova, E. I. Khatkova, E. A. Arutiunian, E. I. Volkova, L. G. Zhukova
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 75-82 (2021)
Introduction. Сombination of alpelisib plus fulvestrant is approved in patients with hormone receptor positive, HER2-negative, PIK3CA-mutated advanced breast cancer (ABC) after progression on hormonotherapy. Efficacy data of alpelisib in heavily pre
Externí odkaz:
https://doaj.org/article/ad9544f3de50402ba5204d61ffb29821
Autor:
O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, M. V. Sukhova, O. E. Ryabishina, E. V. Lubennikova, D. A. Filonenko, E. I. Chichikov, I. N. Polushkina, E. I. Borisova, A. N. Lud, A. A. Meshcheryakov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 16, Iss 2, Pp 25-37 (2020)
Background. Treatment results for the patients with stage II–III triple negative breast cancer (TN BC) have to be improved. Not only the new treatment regimens, but new predictive and prognostic factors should to be developed.Materials and methods.
Externí odkaz:
https://doaj.org/article/b567c6b98dcc4c59b312427d125b37b7
Autor:
I. P. Ganshina, D. A. Filonenko, O. O. Gordeeva, E. V. Lubennikova, I. V. Kolyadina, A. A. Mescheryakov
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 72-80 (2019)
Breast cancer steadily holds leading market positions in the malignancy morbidity and mortality pattern. The treatment of metastatic breast cancer remains an extremely topical issue, when its aim is not only to prolong the patient’s life, but also
Externí odkaz:
https://doaj.org/article/0d4ac3e1b8334bb0a9193f5af41a4c31
Autor:
D. A. Filonenko, S. V. Petukhova, E. I. Khatkova, K. A. Vorontsova, E. I. Chichikov, B. M. Medvedeva, L. G. Zhukova
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 12-16 (2018)
The survival of patients even with disseminated disease reached 7–8 years after introduction of imatinib and sunitinib for the treatment of gastrointestinal stromal tumours (GIST) into everyday clinical practice. These drugs efficacy is largely det
Externí odkaz:
https://doaj.org/article/00cf503fcd4e4855be5b85746597314c
Autor:
A. D. Shirin, R. Ya. Vlasenko, N. Yu. Anisimova, K. I. Kirgizov, T. T. Valiev, N. G. Stepanyan, T. Z. Aliev, G. E. Morozevich, O. A. Odaryuk, D. V. Filonenko, N. E. Nifantiev, K. M. Novruzov, I. O. Chikileva, M. V. Kiselevskiy
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:64-74
Conditioning regimens prior to hematopoietic stem cell transplantation (HSCT) are often accompanied by a period of aplasia characterized by severe neutropenia, anemia, and thrombocytopenia. Long-term antibacterial and immunosuppressive therapy in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5445c331ccb2a34270fca71863c5554c
https://doi.org/10.21682/2311-1267-2022-9-4-64-74
https://doi.org/10.21682/2311-1267-2022-9-4-64-74
Autor:
K. S. Grechukhina, K. A. Vorontsova, D. A. Filonenko, P. S. Tyutyunnik, V. V. Shchadrova, V. V. Glebovskaya, L. G. Zhukova
Publikováno v:
Meditsinskiy sovet = Medical Council. :42-51
For patients with the metastatic subtype of luminal HER-2-negative (HR+/HER2-) breast cancer (mBC) in the absence of visceral crisis, the gold standard of treatment is a combination of CDK4/6 inhibitors and aromatase inhibitors, regardless of their m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3431afa6629dedce363937a8baaacde4
https://doi.org/10.21518/2079-701x-2022-16-22-42-51
https://doi.org/10.21518/2079-701x-2022-16-22-42-51
Autor:
N. S. Martynenko, N. Yu. Anisimova, M. V. Kiselevskiy, O. V. Rybalchenko, D. R. Temralieva, D. V. Prosvirnin, S. V. Pivovarchik, D. V. Filonenko, S. V. Dobatkin
Publikováno v:
Russian Journal of Biotherapy. 21:40-49
Background. Zinc alloys have advantages for use as biodegradable implantable orthopedic metal structures due to the absence of gas formation in comparison with magnesium alloys. But their mechanical properties are often has lower values.Aim. Investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68c9d8a4e31e7dc2987b834c7487264b
https://doi.org/10.17650/1726-9784-2022-21-3-40-49
https://doi.org/10.17650/1726-9784-2022-21-3-40-49
Autor:
I V Kolyadina, I P Ganshina, L G Zhukova, A G Abdullaev, Yu Yu Andreeva, T Yu Danzanova, G T Sinyukova, D V Komov, N A Kozlov, D A Filonenko, O O Gordeeva, E V Lubennikova
Publikováno v:
Современная онкология, Vol 19, Iss 4, Pp 36-38 (2017)
Soft tissue metastases of the gluteal region in solid tumors observed very rarely. We described a unique clinical case of gluteal soft tissue metastases in HER2+ breast cancer; through close collaboration were able to confirm the progression of the b
Externí odkaz:
https://doaj.org/article/9d57e219a18443aab4fa1631074cb529
Autor:
A. I. Khovavko, A. A. Nebesnyi, D. S. Filonenko, M. Yu. Barabash, A. A. Kolesnichenko, A. M. Sviatenko, S. Ya. Brichka, Guochao Nie
Publikováno v:
Springer Proceedings in Physics ISBN: 9783031180958
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55536ee7d1b9a4bd795ff8ad899daad4
https://doi.org/10.1007/978-3-031-18096-5_4
https://doi.org/10.1007/978-3-031-18096-5_4
